Genzyme

Proteostasis names Enyedy CEO

Thursday, October 20, 2011 10:27 AM

Proteostasis Therapeutics has named Mark J. Enyedy chief executive officer. Enyedy joins Proteostasis after serving 15 years at Genzyme, most recently as president of the transplant, oncology and multiple sclerosis divisions. Enyedy has also been elected to the Proteostasis board of directors.

More... »

Oncobiologics names Canute to board of directors

Wednesday, October 12, 2011 11:31 AM

Oncobiologics has named Scott Canute to its board of directors.

More... »

Aldredge joins Expression Analysis

Wednesday, September 21, 2011 10:57 AM

Expression Analysis, a provider of genetic and genomic testing and analysis for the pharmaceutical and biotechnology industries, has named Tyler Aldredge vice president of laboratory operations.

More... »

Former Genzyme chief donates $10 million to MGH

Wednesday, September 14, 2011 11:00 AM

Retired biotechnology executive Henri A. Termeer, who built Genzyme into the largest US company specializing in drugs to treat rare genetic disorders, is donating $10 million to Massachusetts General Hospital to establish it as a world leader in personalized medicine, according to the Boston Globe.

More... »

Roche names president of Ventana Medical Systems

Monday, August 1, 2011 12:09 PM

Ventana Medical Systems, a member of the Roche Group, has named Mara Aspinall president. Aspinall will begin her new role at Ventana in September 2011.

More... »

Venture capital funding for biotech soars 46%

Wednesday, July 20, 2011 01:52 PM

Venture capital funding in biotechnology companies jumped 46% in the second quarter, as investors looked to replenish their portfolios after an increase in acquisitions and initial public offerings, according to Bloomberg News.

More... »

Sanofi: Genzyme unit may be smaller

Thursday, June 2, 2011 11:16 AM

Sanofi has told employees of Cambridge, Mass.-based Genzyme, the biotech Sanofi acquired in April, that they will have a new reporting structure within the parent company, according to The Boston Globe.

More... »

Layoffs at Genzyme Genetics

Monday, April 25, 2011 12:18 PM

Massachusetts-based Genzyme Genetics employees received word that 169 workers would be laid-off in the IT and reimbursement departments, according to Fierce BiotechIT.

More... »

Aveo Pharmaceuticals appoints Henri Termeer to board

Tuesday, April 12, 2011 12:33 PM

Cambridge, Mass.-based Aveo Pharmaceuticals will the appoint Henri A. Termeer, outgoing chairman, president and chief executive officer of Genzyme, to its board of directors.

More... »

Genzyme sells pharmaceuticals segment

Monday, March 7, 2011 10:49 AM

Cambridge, Mass.-based Genzyme has completed the sale of its pharmaceutical intermediates business to Germany's International Chemical Investors Group for an undisclosed amount, according to BIOSmartBrief.

More... »